Hypothesis: Unrecognized actions of ENaC blockade in improving refractory-resistant hypertension and residual cardiovascular risk.
作者信息
Elijovich Fernando, Kirabo Annet, Laffer Cheryl L
机构信息
Division of Clinical Pharmacology. Department of Medicine. Vanderbilt University School of Medicine, 2220 Pierce Ave, 536 RRB, Nashville, TN, 37232, USA.
出版信息
Int J Cardiol Hypertens. 2020 Sep 12;7:100048. doi: 10.1016/j.ijchy.2020.100048. eCollection 2020 Dec.
Abstract
摘要
Zotero 插件